Though ischemic outcomes numerically favored the Amulet, confirmation in future studies is needed, experts say.

Boston Scientific (NYSE:BSX) stock climbed 5% Monday after the medical device maker announced a study has shown its Watchman FLX device was superior to oral anti-coagulant medication in reducing ...